UpHealth (UPHL) Competitors $0.0002 0.00 (0.00%) As of 08/22/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock UPHL vs. BTTX, OPGN, ACONW, AONC, DHACW, FMS, LFMDP, OTRKP, PIIIW, and TALKWShould you be buying UpHealth stock or one of its competitors? The main competitors of UpHealth include Better Therapeutics (BTTX), OpGen (OPGN), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Fresenius Medical Care AG & Co. KGaA (FMS), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), and Talkspace (TALKW). These companies are all part of the "healthcare" industry. UpHealth vs. Its Competitors Better Therapeutics OpGen Aclarion American Oncology Network Digital Health Acquisition Fresenius Medical Care AG & Co. KGaA LifeMD Ontrak P3 Health Partners Talkspace Better Therapeutics (NASDAQ:BTTX) and UpHealth (NYSE:UPHL) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, media sentiment, profitability, risk and earnings. Which has stronger valuation and earnings, BTTX or UPHL? Better Therapeutics has higher earnings, but lower revenue than UpHealth. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBetter TherapeuticsN/AN/A-$39.76MN/AN/AUpHealth$130M0.00-$56.42M-$1.350.00 Does the media prefer BTTX or UPHL? In the previous week, Better Therapeutics' average media sentiment score of 0.00 equaled UpHealth'saverage media sentiment score. Company Overall Sentiment Better Therapeutics Neutral UpHealth Neutral Do institutionals & insiders have more ownership in BTTX or UPHL? 34.0% of Better Therapeutics shares are owned by institutional investors. Comparatively, 56.1% of UpHealth shares are owned by institutional investors. 51.4% of Better Therapeutics shares are owned by insiders. Comparatively, 34.2% of UpHealth shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more volatility & risk, BTTX or UPHL? Better Therapeutics has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500. Comparatively, UpHealth has a beta of 0.85, suggesting that its share price is 15% less volatile than the S&P 500. Is BTTX or UPHL more profitable? Company Net Margins Return on Equity Return on Assets Better TherapeuticsN/A N/A N/A UpHealth N/A N/A N/A SummaryBetter Therapeutics beats UpHealth on 3 of the 5 factors compared between the two stocks. Get UpHealth News Delivered to You Automatically Sign up to receive the latest news and ratings for UPHL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding UPHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPHL vs. The Competition Export to ExcelMetricUpHealthHealth services IndustryMedical SectorNYSE ExchangeMarket Cap$4K$70.11M$5.83B$21.32BDividend YieldN/AN/A4.40%3.51%P/E Ratio0.00N/A31.3029.14Price / Sales0.009.02455.2555.22Price / CashN/A4.0238.0224.09Price / Book0.001.159.535.47Net Income-$56.42M-$30.80M$3.26B$992.74M7 Day PerformanceN/A-12.95%2.14%2.68%1 Month PerformanceN/A-4.66%2.81%1.53%1 Year PerformanceN/A511.27%30.70%10.77% UpHealth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPHLUpHealthN/A$0.00flatN/A-99.9%$4K$130M0.001,750BTTXBetter TherapeuticsN/A$0.00flatN/AN/A$5KN/A0.0040OPGNOpGenN/A$0.00flatN/A-100.0%$1K$2.67M0.00100ACONWAclarionN/A$0.05+15.7%N/A+49.2%$0.00$62.95K0.007Gap DownAONCAmerican Oncology NetworkN/A$11.06-10.8%N/A+276.6%$0.00$1.34B0.001,520Gap DownDHACWDigital Health AcquisitionN/A$0.03flatN/AN/A$0.00N/A0.00N/AFMSFresenius Medical Care AG & Co. KGaA2.849 of 5 stars$25.19+0.8%$27.80+10.4%+34.6%$0.00$20.63B20.641,384News CoverageNegative NewsAnalyst UpgradeShort Interest ↑LFMDPLifeMDN/A$24.11+0.4%N/A+9.9%$0.00$245.56M0.00230Positive NewsOTRKPOntrakN/A$0.02+112.9%N/A-90.5%$0.00$10.84M0.00250Gap UpHigh Trading VolumePIIIWP3 Health PartnersN/A$0.01-0.9%N/A-55.9%$0.00$1.46B0.00500TALKWTalkspaceN/A$0.07-5.2%N/A+66.2%$0.00$202.61M0.00500Gap Down Related Companies and Tools Related Companies BTTX Alternatives OPGN Alternatives ACONW Alternatives AONC Alternatives DHACW Alternatives FMS Alternatives LFMDP Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:UPHL) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding UpHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share UpHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access